Skip to main content

Vaccines Will Be Best Defense Against Bird Flu, Experts Say

Medically reviewed by Carmen Pope, BPharm. Last updated on May 29, 2024.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, May 29, 2024 -- Humanity’s best protection against bird flu will be the development of effective vaccines, a new study says.

The H5N1 avian flu has been raging through cattle and poultry in the United States, increasing fears that the virus will make the leap into humans and potentially cause another pandemic.

Only two people to date are known to have contracted the virus linked to the current outbreak. Both patients were U.S. farm workers, and luckily they only suffered eye symptoms and made a full recovery with treatment, researchers said.

In the first human case, researchers found the strain had mutated to be better at infecting the cells of mammals.

The concern is that if H5N1 continues to spread in U.S. farms, it has the potential to mutate into a form that will easily spread among humans, researchers said.

Vaccines remain humanity’s best defense against the threat posed by the H5N1 and other strains of bird flu, according to the research published in the journal Human Vaccines & Immunotherapeutics.

“The H5N1, H7N9, and H9N2 subtypes of avian influenza virus pose a dual threat, not only causing significant economic losses to the global poultry industry but also presenting a pressing public health concern due to documented spillover events and human cases,” said lead researcher Dr. Flavio Cargnin Faccin, a doctoral student with the University of Georgia.

“This deep delve into the landscape of avian influenza vaccines for humans shows vaccination remains the primary defense against the spread of these viruses,” Faccin said in a journal news release.

The researchers analyzed a number of different vaccine types -- inactivated vaccines, live attenuated flu vaccines and mRNA vaccines -- and determined they all show promise in protecting animals and people from the avian flu.

Overall, the team suggests “exploring and employing a diverse range of vaccine platforms ”will be “crucial for enhancing pandemic preparedness and mitigating the threat of avian influenza viruses.”

Work along those lines already is proceeding in mRNA vaccines.

A study published last week reported that an experimental mRNA vaccine against the H5N1 avian flu was effective in preventing serious illness and death in lab mice and ferrets.

The lab animals maintained high levels of antibodies a year after infection, and vaccinated animals infected with H5N1 cleared the virus quicker and suffered fewer symptoms than unvaccinated animals, researchers reported in the journal Nature Communications.

Sources

  • Taylor and Francis, news release, May 29, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted May 2024

Read this next

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

THURSDAY, May 22, 2025 — The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines. The updated...

FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups

WEDNESDAY May 21, 2025 — The U.S. Food and Drug Administration (FDA) has decided that only seniors and people at high risk should get the latest COVID-19 booster shots this...

FDA Gives Full OK to Novavax COVID Shot for High-Risk Groups

MONDAY, May 19, 2025 — The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax’s COVID-19 vaccine, but only for certain people. The vaccine...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.